The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding what matters to metastatic castration-resistant prostate cancer (mCRPC) patients when considering treatment options: A US survey.
 
Daniel J. George
Leadership - Capio BioSciences
Honoraria - Acceleron Pharma; American Association for Cancer Research; Axess Oncology; Bayer; EMD Serono; Exelixis; Janssen Oncology; Millennium Medical Publishing; OncLive; Pfizer; Sanofi; UroToday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Constellation Pharmaceuticals; Exelixis; Genentech; Innocrin Pharma; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Myovant Sciences; Pfizer; Physicans' Education Resource; Propella Therapeutics; RevHealth; Sanofi
Speakers' Bureau - Bayer; Exelixis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Dendreon (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi; UroToday
 
Ateesha F. Mohamed
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Jui-Hua Tsai
Employment - OPEN Health
Stock and Other Ownership Interests - Moderna Therapeutics
Research Funding - AstraZeneca (Inst); Avanir (Inst); Bayer (Inst); EMD Serono (Inst); Insmed (Inst); Magenta Therapeutics (Inst); Medtronic (Inst); Taiho Oncology (Inst); Takeda (Inst); Vertex (Inst)
 
Milad Karimi
Employment - OPEN Health
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); EuroQoL Group (Inst); Galderma (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Pfizer (Inst); Seagen (Inst); SERVIER (Inst); Taiho Oncology (Inst)
 
Ning Ning
Consulting or Advisory Role - Bayer (Inst); BeiGene (Inst); Bristol Myers Squibb (Inst); Daiichi Sankyo (Inst); Merck (Inst); Otsuka (Inst); Takeda (Inst)
 
Sayeli Jayade
Employment - OPEN Health
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Seagen (Inst); Taiho Oncology (Inst)
 
Marc Botteman
Employment - OPEN Health
Leadership - OPEN Health
Stock and Other Ownership Interests - OPEN Health
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Helsinn Therapeutics (Inst); Kite/Gilead (Inst); Merck Sharp & Dohme Oncology (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Helsinn Therapeutics (Inst); Kite/Gilead (Inst); Merck Sharp & Dohme Oncology (Inst)
Other Relationship - OPEN Health